Zacks
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
📊
AI Sentiment
Positive
6/10
- Home
- A
as of 02-26-2026 9:37am EST
$119.90
$4.83
-3.87%
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 39.8B | IPO Year: | 1999 |
| Target Price: | $165.13 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 4.57 | EPS Growth: | 3.16 |
| 52 Week Low/High: | $96.43 - $160.27 | Next Earning Date: | 05-27-2026 |
| Revenue: | $4,472,000,000 | Revenue Growth: | 6.43% |
| Revenue Growth (this year): | 8.03% | Revenue Growth (next year): | 6.22% |
| P/E Ratio: | 27.29 | Index: | |
| Free Cash Flow: | 1.2B | FCF Growth: | -24.31% |
Stock Insider Trading Activity of Agilent Technologies Inc. (A)
Dolsten Mikael
Sell
Director
A Dec 1, 2025
Avg Cost/Share
$149.81
Shares
2,600
Total Value
$389,511.20
Owned After
4,973.028
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dolsten Mikael | A | Director | Dec 1, 2025 | Sell | $149.81 | 2,600 | $389,511.20 | 4,973.028 |
Latest Agilent Technologies Inc. News
A Breaking Stock News: Dive into A Ticker-Specific Updates for Smart Investing
Insider Monkey
Agilent Technologies, Inc. (A) Sparks Confidence With Latest Approvals
📈
AI Sentiment
Highly Positive
9/10
GuruFocus.com
Agilent Technologies Inc (STU:AG8) Q1 2026 Earnings Report Preview: What To Look For
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Is It Time To Reassess Agilent Technologies (A) After Recent Share Price Weakness
âž–
AI Sentiment
Neutral
4/10
Business Wire
Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference
âž–
AI Sentiment
Neutral
5/10
Zacks
If You Invested $1000 in Keysight a Decade Ago, This is How Much It'd Be Worth Now
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading
📈
AI Sentiment
Highly Positive
9/10
Compare A vs Leading Stocks
See how A stacks up against similar companies in the market
Head-to-Head Comparisons
More Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "A Agilent Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.